| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |